Viale A., Corti D., Draetta G.F. 2015. Tumors and mitochondrial respiration: A neglected connection. Cancer Res. 75, 3687.

Article  CAS  Google Scholar 

Bensinger S.J., Christofk H.R. 2012. New aspects of the Warburg effect in cancer cell biology. Semin. Cell Dev. Biol. 23, 352–361.

Article  CAS  PubMed  Google Scholar 

Solaini G., Sgarbi G., Baracca A. 2011. Oxidative phosphorylation in cancer cells. Biochim. Biophys. Acta, Bioenerg. 1807, 534–542.

Article  CAS  Google Scholar 

Cluntun A.A., Lukey M.J., Cerione R.A., Locasale J.W. 2017. Glutamine metabolism in cancer: Understanding the heterogeneity. Trends Cancer. 3, 169–180.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao Y. 2019. Adipocyte and lipid metabolism in cancer drug resistance. J. Clin. Invest. 129, 3006–3017.

Article  PubMed  PubMed Central  Google Scholar 

Gerashchenko T.S., Denisov E.V., Litvyakov N.V., Zavyalova M.V., Vtorushin S.V., Tsyganov M.M., Perelmuter V.M., Cherdyntseva N.V. 2013. Intratumoral heterogeneity: Nature and biological significance. Biochemistry (Moscow). 78, 1531–1549.

Google Scholar 

Nassar A., Radhakrishnan A., Cabrero I.A., Cotsonis G.A., Cohen C. 2010. Intratumoral heterogeneity of immunohistochemical marker expression in breast carcinoma: A tissue microarray-based study. Appl. Immunohistochem. Mol. Morphol. 18, 433–441.

Article  CAS  PubMed  Google Scholar 

Somasundaram R., Villanueva J., Herlyn M. 2012. Intratumoral heterogeneity as a therapy resistance mechanism. Adv. Pharmacol. 65, 335–359.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fisher R., Pusztai L., Swanton C. 2013. Cancer heterogeneity: Implications for targeted therapeutics. Br. J. Cancer. 108, 479–585.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prasetyanti P.R., Medema J.P. 2017. Intra-tumor heterogeneity from a cancer stem cell perspective. Mol. Cancer. 16, 41.

Article  PubMed  PubMed Central  Google Scholar 

Marusyk A., Polyak K. 2010. Tumor heterogeneity: Causes and consequences. Biochim. Biophys. Acta, Rev. Cancer. 1805, 105–117.

CAS  Google Scholar 

McGranahan N., Swanton C. 2017. Clonal heterogeneity and tumor evolution: Past, present, and the future. Cell. 168, 613–628.

Article  CAS  PubMed  Google Scholar 

Allis C.D., Jenuwein T. 2016. The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17, 487–500.

Article  CAS  PubMed  Google Scholar 

Kim J., DeBerardinis R.J. 2019. Mechanisms and implications of metabolic heterogeneity in cancer. Cell Metabolism. 30, 434–446.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chekhun V.F., Sherban S.D., Savtsova Z.D. 2012. Tumor heterogeneity is a dynamic state. Onkologiya. 14, 4–12.

Google Scholar 

Hanahan D., Weinberg R.A. 2011. Hallmarks of cancer: The next generation. Cell. 144, 646–674.

Article  CAS  PubMed  Google Scholar 

Clevers H. 2011. The cancer stem cell: Premises, promises and challenges. Nat. Med. 17, 313–319.

Article  CAS  PubMed  Google Scholar 

Murata M. 2018. Inflammation and cancer. Environ. Healthcare Prev. Med. 23, 50.

Article  Google Scholar 

Xiao Z., Dai Z., Locasale J.W. 2019. Metabolic landscape of the tumor microenvironment at single cell resolution. Nat. Commun. 10, 3763.

Article  PubMed  PubMed Central  Google Scholar 

Balkwill F., Mantovani A. 2001. Inflammation and cancer: Back to Virchow? Lancet. 357, 539–545.

Article  CAS  PubMed  Google Scholar 

Korkaya H., Kim G.I., Davis A., Malik F., Henry N.L., Ithimakin S., Quraishi A.A., Tawakkol N., D’Angelo R., Paulson A.K., Chung S., Luther T., Paholak H.J., Liu S., Hassan K.A., Zen Q., Clouthier S.G., Wicha M.S. 2012. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol. Cell. 47, 570–584.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brosalov V.M., Sudapina A.R., Mikulyak N.I. 2020. Clonal evolution of breast cancer: Current perspectives on a longstanding theory (literature review). Izv. Vyssh. Uchebn. Zaved., Povolzh. Reg., Med. Nauki. 2, 109–119. 2, 109–119.

Michor F., Polyak K. 2010. The origins and implications of intratumor heterogeneity. Cancer Prevention Res. 3, 1361–1364.

Article  Google Scholar 

Warmoes M.O., Locasale J.W. 2014. Heterogeneity of glycolysis in cancers and therapeutic opportunities. Biochem. Pharmacol. 92, 12–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diaz-Ruiz R., Rigoulet M., Devin A. 2011. The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim. Biophys. Acta, Bioenergetics. 1807, 568–576.

Article  CAS  Google Scholar 

Vander Heiden M.G., Cantley L.C., Thompson C.B. 2009. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science. 324, 1029–1033.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stern R., Shuster S., Neudecker B.A., Formby B. 2002. Lactate stimulates fibroblast expression of hyaluronan and CD44: The Warburg effect revisited. Exp. Cell Res. 276, 24–31.

Article  CAS  PubMed  Google Scholar 

Sonveaux P., Copetti T., De Saedeleer C.J., Végran F., Verrax J., Kennedy K.M., Moon E.J., Dhup S., Danhier P., Frérart F., Gallez B., Ribeiro A., Michiels C., Dewhirst M.W., Feron O. 2012. Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. PLoS One. 7, e33418.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cairns R.A., Harris I.S., Mak T.W. 2011. Regulation of cancer cell metabolism. Nat. Rev. Cancer. 11, 85–95.

Article  CAS  PubMed  Google Scholar 

Lunt S.Y., Vander Heiden M.G. 2011. Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 27, 441–464.

Article  CAS  PubMed  Google Scholar 

Cantor J.R., Sabatini D.M. 2012. Cancer cell metabolism: One hallmark, many faces. Cancer Discov. 2, 881–898.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smolková K., Bellance N., Scandurra F., Génot E., Gnaiger E., Plecitá-Hlavatá L., Ježek P., Rossignol R. 2010. Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. J. Bioenerg. Biomembr. 42, 55–67.

Article  PubMed  Google Scholar 

Pavlova N.N., Thompson C.B. 2016. The emerging hallmarks of cancer metabolism. Cell Metabolism. 23, 27–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sengupta D., Pratx G. 2016. Imaging metabolic heterogeneity in cancer. Mol. Cancer. 15, 4.

Article  PubMed  PubMed Central  Google Scholar 

Sancho P., Barneda D., Heeschen C. 2016. Hallmarks of cancer stem cell metabolism. Br. J. Cancer. 114, 1305–1312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ganapathy-Kanniappan S. 2018. Molecular intricacies of aerobic glycolysis in cancer: Current insights into the classic metabolic phenotype. Crit. Rev. Biochem. Mol. Biol. 53, 667–682.

Article  CAS  PubMed  Google Scholar 

Seth Nanda C., Venkateswaran S.V., Patani, N., Yuneva M. 2020. Defining a metabolic landscape of tumours: Genome meets metabolism. Br. J. Cancer. 122, 136–149.

Article  CAS  PubMed  Google Scholar 

Harami-Papp H., Pongor L.S., Munkacsy G., Horvath G., Nagy A.M., Ambrus A., Hauser P., Szabo A., Tretter L., Gyorffy, B. 2016. TP53 mutation hits energy metabolism and increases glycolysis in breast cancer. Oncotarget. 7, 67183–67195.

Article  PubMed  PubMed Central  Google Scholar 

Zhang X., Wang J., Zhuang J., Liu C., Gao C., Li H., Ma X., Li J., Sun C. 2021. A novel glycolysis-related four-mRNA signature for predicting the survival of patients with breast cancer. Front. Genet. 12, 606937.

Article  CAS  PubMed